Published in Eur Arch Psychiatry Clin Neurosci on September 13, 2014
Altered functional connectivity density in major depressive disorder at rest. Eur Arch Psychiatry Clin Neurosci (2015) 0.89
Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice. Sci Rep (2015) 0.86
Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression. Psychopharmacology (Berl) (2015) 0.84
Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities. Neuropsychopharmacology (2016) 0.76
Differential effects of rumination and distraction on ketamine induced modulation of resting state functional connectivity and reactivity of regions within the default-mode network. Soc Cogn Affect Neurosci (2016) 0.75
The Risk of Upper Urinary Tract Involvement in Patients With Ketamine-Associated Uropathy. Int Neurourol J (2017) 0.75
A default mode of brain function. Proc Natl Acad Sci U S A (2001) 50.73
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell (2003) 12.50
The molecular biology of memory storage: a dialogue between genes and synapses. Science (2001) 11.85
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry (2006) 11.84
mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science (2010) 10.97
Antidepressant effects of ketamine in depressed patients. Biol Psychiatry (2000) 10.91
Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell (2007) 8.99
Experience-dependent structural synaptic plasticity in the mammalian brain. Nat Rev Neurosci (2009) 7.54
The molecular neurobiology of depression. Nature (2008) 6.51
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct (2008) 6.32
Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science (2006) 5.89
Postsynaptic receptor trafficking underlying a form of associative learning. Science (2005) 5.80
Synaptic AMPA receptor plasticity and behavior. Neuron (2009) 5.58
Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci (1997) 5.30
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci (2008) 5.12
Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci (2003) 5.11
mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci (2009) 5.04
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry (2013) 4.84
Cingulate function in depression: a potential predictor of treatment response. Neuroreport (1997) 4.48
Dynamic functional connectivity: promise, issues, and interpretations. Neuroimage (2013) 4.39
Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology (2007) 4.38
NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci (2007) 4.35
BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol (2005) 4.34
Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn Sci (2011) 4.26
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry (2008) 4.06
The default mode network and self-referential processes in depression. Proc Natl Acad Sci U S A (2009) 4.05
Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry (2000) 4.03
Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry (2010) 4.00
Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry (2009) 3.96
A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science (2010) 3.61
Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biol Psychiatry (2006) 3.45
Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proc Natl Acad Sci U S A (2010) 3.42
Neural mechanisms of the cognitive model of depression. Nat Rev Neurosci (2011) 3.10
Default-mode and task-positive network activity in major depressive disorder: implications for adaptive and maladaptive rumination. Biol Psychiatry (2011) 3.09
Emotion enhances learning via norepinephrine regulation of AMPA-receptor trafficking. Cell (2007) 3.00
Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology (2010) 2.97
From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem (2002) 2.79
Molecular mechanisms of memory acquisition, consolidation and retrieval. Curr Opin Neurobiol (2001) 2.78
Glutamate receptor function in learning and memory. Behav Brain Res (2003) 2.72
Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry (2012) 2.69
The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol (2010) 2.64
Reward and punishment processing in depression. Biol Psychiatry (2010) 2.62
Dendritic spine formation and stabilization. Curr Opin Neurobiol (2009) 2.59
Ketamine administration in depressive disorders: a systematic review and meta-analysis. Psychopharmacology (Berl) (2014) 2.37
The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci (2011) 2.36
Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J Neurosci (2004) 2.29
A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol (2008) 2.23
Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology (1999) 1.97
Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res (2005) 1.96
Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am J Psychiatry (2005) 1.84
GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology (2012) 1.74
Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist. Biol Psychiatry (2008) 1.71
A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry (2014) 1.69
Altered negative BOLD responses in the default-mode network during emotion processing in depressed subjects. Neuropsychopharmacology (2008) 1.69
Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology (2010) 1.65
BDNF activates mTOR to regulate GluR1 expression required for memory formation. PLoS One (2009) 1.63
Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression. Behav Brain Res (2011) 1.62
The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. Arch Gen Psychiatry (2009) 1.61
Stuck in a rut: rethinking depression and its treatment. Trends Neurosci (2010) 1.60
Neuropsychological impairment in patients with major depressive disorder: the effects of feedback on task performance. Psychol Med (2003) 1.59
A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder. J Affect Disord (2011) 1.58
BDNF and memory formation and storage. Neuroscientist (2007) 1.56
Ventral striatum response during reward and punishment reversal learning in unmedicated major depressive disorder. Am J Psychiatry (2012) 1.55
Glutamatergic and resting-state functional connectivity correlates of severity in major depression - the role of pregenual anterior cingulate cortex and anterior insula. Front Syst Neurosci (2010) 1.54
Cognitive impairment in major depression. Eur J Pharmacol (2009) 1.52
Time-resolved resting-state brain networks. Proc Natl Acad Sci U S A (2014) 1.48
Receptor architecture of human cingulate cortex: evaluation of the four-region neurobiological model. Hum Brain Mapp (2009) 1.48
A pathway-specific function for different AMPA receptor subunits in amygdala long-term potentiation and fear conditioning. J Neurosci (2007) 1.44
A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. Psychol Med (2014) 1.43
Positive AMPA receptor modulation rapidly stimulates BDNF release and increases dendritic mRNA translation. J Neurosci (2009) 1.38
Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology (2009) 1.36
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci (2010) 1.36
Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia. Hippocampus (2001) 1.35
Ketamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action. PLoS One (2012) 1.27
Ketamine: behavioral effects of subanesthetic doses. J Clin Psychopharmacol (1985) 1.27
Association between heart rate variability and fluctuations in resting-state functional connectivity. Neuroimage (2012) 1.26
Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses. Proc Natl Acad Sci U S A (2014) 1.26
Hippocampal long-term depression mediates acute stress-induced spatial memory retrieval impairment. Proc Natl Acad Sci U S A (2007) 1.26
BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons. Mol Cell Neurosci (2007) 1.24
Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders. Eur Arch Psychiatry Clin Neurosci (2013) 1.24
Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci (1982) 1.18
Do the dissociative side effects of ketamine mediate its antidepressant effects? J Affect Disord (2014) 1.18
Transcriptional regulation of brain-derived neurotrophic factor in the amygdala during consolidation of fear memory. Mol Pharmacol (2007) 1.16
Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar-Kyoto rats. Neuroscience (2012) 1.14
Serial infusions of low-dose ketamine for major depression. J Psychopharmacol (2013) 1.12
Acute and chronic effects of ketamine upon human memory: a review. Psychopharmacology (Berl) (2006) 1.10
Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol (2013) 1.10
Differential activation of brain-derived neurotrophic factor gene promoters I and III by Ca2+ signals evoked via L-type voltage-dependent and N-methyl-D-aspartate receptor Ca2+ channels. J Biol Chem (2000) 1.08
Depression is related to an absence of optimistically biased belief updating about future life events. Psychol Med (2013) 1.08
Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy. Ther Adv Psychopharmacol (2014) 1.06
Neuronal network plasticity and recovery from depression. JAMA Psychiatry (2013) 1.06
The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice. Psychopharmacology (Berl) (2010) 1.05
Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Eur Psychiatry (2013) 1.04
Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers. Psychopharmacology (Berl) (2000) 1.02
Simultaneous PET-MRI reveals brain function in activated and resting state on metabolic, hemodynamic and multiple temporal scales. Nat Med (2013) 1.00
Modulation of learning processes by ionotropic glutamate receptor ligands. Behav Pharmacol (1995) 1.00
Effect of the BDNF V166M polymorphism on working memory in healthy adolescents. Genes Brain Behav (2006) 1.00
D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders. Biol Mood Anxiety Disord (2013) 0.98
Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study. Cereb Cortex (2004) 0.97
Brain damages in ketamine addicts as revealed by magnetic resonance imaging. Front Neuroanat (2013) 0.97
Global view of the mechanisms of improved learning and memory capability in mice with music-exposure by microarray. Brain Res Bull (2009) 0.78
Self-directedness and the susceptibility to distraction by saliency. Cogn Emot (2015) 0.75